A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa

This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.

Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Hidradenitis Suppurativa Bacterial Infections Bacterial Infections and Mycoses Hidradenitis Infections Skin Diseases Skin Diseases, Bacterial Skin Diseases, Infectious Skin and Connective Tissue Diseases Suppuration Sweat Gland Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged ≥ 18 years old
Diagnosis of hidradenitis suppurativa
Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

Female patients who are currently pregnant or nursing
Inability to perform regular electronic reporting
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.

Treatment and study plan

Primary outcomes

Number of hidradenitis suppurativa patients who decide to enroll in a clinical research

Time frame: 3 months
Rate of hidradenitis suppurativa patients who remain in clinical trial to trial completion

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

415-900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Examining Engagement Trends Among Participants in Hidradenitis Suppurativa Clinical Trials

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2027
First posted: Jan 11, 2024
Registry last updated: Feb 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting